A KCa1.1/BK activator
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

NS 19504

Item No. 43669

Technical Information
Formal Name
5-[(4-bromophenyl)methyl]-2-thiazolamine
CAS Number
327062-46-4
Molecular Formula
C10H9BrN2S
Formula Weight
Purity
≥98%
Formulation
A solid
DMSO: Soluble: ≥10 mg/mlEthanol: Soluble: ≥10 mg/ml
SMILES
BrC1=CC=C(CC2=CN=C(N)S2)C=C1
InChi Code
InChI=1S/C10H9BrN2S/c11-8-3-1-7(2-4-8)5-9-6-13-10(12)14-9/h1-4,6H,5H2,(H2,12,13)
InChi Key
HGWLTZOMQZIUBW-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    NS 19504 is an activator of large-conductance calcium-activated potassium channels (KCa1.1/BK).1 It induces currents in whole-cell patch-clamp assays using HEK293 cells expressing human KCa1.1/BK when used at a concentration of 10 µM. NS 19504 decreases the force of spontaneous phasic contractions in isolated and perfused guinea pig bladder smooth muscle strips (EC50 = 640 nM). It inhibits methoxamine-induced contractions in isolated rat saphenous arteries when used at a concentration of 6 µM.2

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Nausch, B., Rode, F., Jørgensen, S., et alNS19504: A novel BK channel activator with relaxing effect on bladder smooth muscle spontaneous phasic contractions. J. Pharmacol. Exp. Ther. 350(3), 520-530 (2014).

    2. Ma, D., Gaynullina, D., Schmidt, N., et alThe functional availability of arterial Kv7 channels is suppressed considerably by large-conductance calcium-activated potassium channels in 2- to 3-month old but not in 10- to 15-day old rats. Front. Physiol. 11, 597395 (2020).